Jun 23, 2020 / 06:30PM GMT
Robert Adam Hopkins - BofA Merrill Lynch, Research Division - MD of Equity Research
Okay. Good afternoon, everybody, and welcome to the next presentation. I'm Bob Hopkins, here with Geoff Meacham who covers large-cap pharma and devices. And this next section, we're thrilled to have J&J here with us for a fireside chat. Joe Wolk, J&J's well-known Executive Vice President, Chief Financial Officer, is on with us; as well as Chris and Lisa and Matt from the Investor Relations team. And just a quick plug for that team. They are a phenomenal resource for investors, and I encourage everybody to take advantage of the great resource that J&J gives to all investors. So Joe, I just want to thank you for joining us this afternoon. It's a pleasure to be with you virtually.
Joseph J. Wolk - Johnson & Johnson - Executive VP & CFO
Bob, thanks for your time and your interest as well as that, that's extended by everybody on the phone. Certainly appreciate being invited by yourself and Geoff to talk a little bit about our company today.
Johnson & Johnson at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Jun 23, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers